New JAMA Study Shows Tongxinluo Improves Outcomes for STEMI Heart Attack Patients

A groundbreaking study in the Journal of the American Medical Association (JAMA) suggests that Tongxinluo, a Traditional Chinese Medicine (TCM) compound, can improve clinical outcomes for patients suffering from ST-elevation myocardial infarction (STEMI), one of the most dangerous types of heart attacks. The study, involving nearly 3,800 STEMI patients in China, found that when combined with guideline-directed care, Tongxinluo significantly reduced the rates of major adverse cardiac and cerebrovascular events over 30 days, three months, and one year.

Tongxinluo, made from extracts of plants and insects, has been shown to decrease the risk of complications associated with STEMI, although the exact mechanism and active ingredients remain to be fully understood. This exciting discovery points to the potential for integrating Traditional Chinese Medicine with conventional heart disease treatments to improve patient outcomes. However, while beneficial, Tongxinluo did show more side effects, specifically gastrointestinal issues, compared to a placebo.

This research opens the door for further studies to determine how TCM compounds like Tongxinluo can complement modern heart disease treatment, offering an exciting new approach to reducing risk and improving long-term health outcomes in patients suffering from severe heart attacks.

More news at https://acupuncturetoday.com/article/34449-tcm-for-the-heart-new-jama-study

Call Now for Acupuncture Treatments and More! +1-201-945-4372